Glucotrack, Inc. Operating Lease Cost
Glucotrack, Inc. (GCTK) reported Operating Lease Cost of $79.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-11-14
- Glucotrack, Inc. operating lease, cost for the quarter ending 2024-09-30 was $0.00.
- Glucotrack, Inc. operating lease, cost for the quarter ending 2024-06-30 was $0.00.
- Glucotrack, Inc. operating lease, cost for the quarter ending 2024-03-31 was $79.00K.
- Glucotrack, Inc. operating lease, cost for the quarter ending 2021-12-31 was $53.00K, a 6.67% decline year-over-year.
- Glucotrack, Inc. operating lease, cost for fiscal 2021 was $171.00K, a 2.29% decline from fiscal 2020.
- Glucotrack, Inc. operating lease, cost for fiscal 2020 was $175.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $79.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $79.00K 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | $79.00K 10-Q · filed 2024-05-15 | |||
| 2021-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $91.00K derived: sum of 2 quarters · filed 2022-03-31 | $127.00K derived: sum of 3 quarters · filed 2022-03-31 | $171.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $74.00K derived: sum of 2 quarters · filed 2021-11-15 | $118.00K 10-Q · filed 2021-11-15 | $174.79K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $80.00K 10-Q · filed 2021-08-16 | $136.79K derived: sum of 3 quarters · filed 2021-08-16 | $175.67K derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | $44.00K 10-Q · filed 2021-05-21 | $100.79K derived: sum of 2 quarters · filed 2021-05-21 | $139.67K derived: sum of 3 quarters · filed 2021-05-21 | $179.33K derived: sum of 4 quarters · filed 2021-05-21 |
| 2020-12-31 | $56.79K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | $95.67K derived: sum of 2 quarters · filed 2021-04-13 | $135.33K derived: sum of 3 quarters · filed 2021-04-13 | $175.00K 10-K · filed 2021-04-13 |
| 2020-09-30 | $38.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $78.55K derived: sum of 2 quarters · filed 2020-11-12 | $118.21K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $39.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $79.33K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $39.67K 10-Q · filed 2020-05-19 | |||
| 2019-09-30 | $31.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $63.89K derived: sum of 2 quarters · filed 2019-11-13 | $95.80K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $31.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $63.83K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $31.91K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |